Antibody Production Market Analysis 2019-2024 | Emerging Technologies, Industry Trends by Market Size, Leading Companies, and Regions


Report Titled: “Antibody Production Market – Growth, Trends, and Forecast (2019 – 2024)

The Research Report on “Antibody Production Market” 2019 report includes every aspect of the Antibody Production industry along with the progress performance. Antibody Production Market report presents an analysis of market size, share, and growth, trends, and price structure, statistical and detailed data of the Antibody Production industry. Additionally, Antibody Production Market 2019 research report offers key analysis on the industry status of the Antibody Production producers with market size, growth, share, trends as well as business price structure.

The Antibody Production Market report is a professional and detailed study on the Antibody Production business. Antibody Production market to predict future market directions between the forecast periods from 2019 to 2024 providing you with vital data for your business decisions.

Get a Sample Copy of the Report –

Scope of the Report:

  • As per the , antibody production refers to the process of creating a specific antibody. In a broad sense, it consists of various methods, such as upstream, downstream, and filtration. The process involves the preparation of antigen samples, which are injected to the laboratory or farm animals to evoke high expression levels of antigen-specific antibodies in the serum, which are then recovered from the animal. The market is expected to witness significant growth, owing to the increase in R&D expenditure of pharmaceutical and biotechnology companies.

    Market Overview:

  • The major factors for the growth of the antibody production market include the rising adoption of targeted immunotherapy, the increase in the R&D expenditure of pharmaceutical and biotechnology companies, and the rising demand for therapeutic antibodies.
  • Antibodies are used in the treatment of various diseases, such as cancer, rheumatoid arthritis, and other chronic diseases. The targeted therapy is attaining importance due to its specificity toward cancer cells while sparing the toxicity to off-target cells. As there is a rising prevalence of cancer, targeted therapies are getting more attention. For instance, according to the estimates of the American Cancer Society, in 2018, there were 1,735,350 new cancer cases diagnosed and 609,640 deaths, due to cancer, in the United States. Some of the examples of monoclonal antibodies used in targeted therapies are bevacizumab, cetuximab, and ipilimumab.
  • The rising adoption of targeted therapies is expected to propel the overall growth of the antibody production market over the forecast period. Furthermore, there is an increase in R&D activities by most of the pharmaceutical and biotechnology companies, in order to develop advanced biologics. The success rates and blockbuster sales of biologics have also made large pharmaceutical companies shift their presence to biopharma. Over the past two decades, the chimerization and humanization of mAbs (monoclonal antibodies) have led to the approval of several for the treatment of autoimmune diseases, cancer, and transplant rejection.
  • However, the costs of antibody production and stringent government regulations are expected to impede the growth of the market.

    Antibody Production Report Also Covers Offer for New Project Includes:

    • Market Entry Strategies
    • Countermeasures of Economic Impact
    • Marketing Channels
    • Feasibility Studies of New Project Investment
    • Research Conclusions of the Antibody Production Industry

    The report provides key statistics on the market status of the Antibody Production Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Antibody Production.

    Enquire Before Purchasing this Report –

    Antibody Production Market Report Also Covers Marketing Strategy Analysis, Top Manufacturers:

  • Applikon Biotechnology Inc.
  • Cellab GmbH
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Genetix Biotech Asia Pvt Ltd
  • Merck KGaA
  • Sartorius AG
  • Solaris Biotech
  • Thermo Fisher Scientific Inc.

    Key Market Trends:

    The Monoclonal Antibodies Segment under the Antibody Type Accounted for the Largest Share in the Global Market

    Monoclonal antibodies have large applications in the field of diagnostics, therapeutics, and targeted drug delivery systems, not only for infectious diseases caused by bacteria, viruses, and protozoa, but also for cancer, metabolic, and hormonal disorders. This segment is expected to account for the largest market share during the forecast period, owing to the rising investment in monoclonal antibody research and an increase in antibody-based product launches. Furthermore, there is a growing collaboration between pharma companies to develop advanced monoclonal antibodies. For instance, recently, in September 2018, Integral Molecular and Merus NV announced that they have entered into a collaboration on multiple undisclosed targets, as Integral Molecular is one of the leaders in membrane protein antibody discovery. The partnership is expected to increase the R&D capabilities of Merus NV.

    The polyclonal antibody segment is expected to be the fastest-growing market, owing to benefits, such as ease of production, low price, and diagnosis of diseases with high proficiency.

    North America Accounted for the Largest Share in the Global Market

    North America is found to hold a significant share in the antibody production market and is expected to show a similar trend over the forecast period, without substantial fluctuations. The presence of favorable healthcare infrastructure and the rising prevalence of various chronic diseases are the major factors driving the growth of the market. Furthermore, there is a rise in the approval of monoclonal antibodies for the treatment of cancer and various types of diseases, which is one of the major factors contributing to the high growth of the market in North America. For instance, in May 2018, Novartis announced that the US FDA approved Kymriah (tisagenlecleucel) suspension for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

    Purchase this Report (Price 4250 USD for Single User License) –

    Detailed TOC of Antibody Production Market Report are:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Adoption of Targeted Immunotherapy
    4.2.2 Increase in the R&D Expenditure of Pharmaceutical and Biotechnology Companies
    4.2.3 Rising Demand for Therapeutic Antibodies
    4.3 Market Restraints
    4.3.1 High Costs Involved in the Antibody Production
    4.3.2 Stringent Government Regulations
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 Antibody Type
    5.1.1 Monoclonal Antibodies
    5.1.2 Polyclonal Antibodies
    5.1.3 Other Antibody Types
    5.2 Process
    5.2.1 Upstream Processing Bioreactors Consumables
    5.2.2 Downstream Processing Chromatography Systems Chromatography Resins
    5.2.3 Filtration
    5.3 End User
    5.3.1 Pharmaceutical and Biotechnology Companies
    5.3.2 Research Laboratories
    5.3.3 Other End Users
    5.4 Geography
    5.4.1 North America US Canada Mexico
    5.4.2 Europe Germany UK France Italy Spain Rest of Europe
    5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.4.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.4.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Applikon Biotechnology Inc.
    6.1.2 Cellab GmbH
    6.1.3 Danaher Corporation
    6.1.4 Eppendorf AG
    6.1.5 GE Healthcare
    6.1.6 Genetix Biotech Asia Pvt Ltd
    6.1.7 Merck KGaA
    6.1.8 Sartorius AG
    6.1.9 Solaris Biotech
    6.1.10 Thermo Fisher Scientific Inc.



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Automotive Electronics Market 2025: Global Size, Key Companies, Trends, Growth and Regional Forecasts Research

    Global Edge Computing Market 2019 by Price Analysis, Supply Chain Analysis, Production, Consumption, Supplier, Cost Structure Market Analysis Forecast to 2025

    Global Biodegradable Packaging Market 2019 Shows Investment Analysis and Future Trends Forecast to 2024